News & Insights

  • Clear

Democratic AGs File Amicus Brief Supporting Drug Pricing Transparency Law

A group of 21 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the Ninth Circuit supporting Oregon in its defense of H.B. 4005, which requires pharmaceutical manufacturers to report certain information about specific new prescription drugs and historical information about pricing for existing drugs. The U.S. District Court for the District of Oregon had…

Read More

California AG Sends Letters Reminding Pharmacies and Health Data Companies of Consumer Privacy Obligations

California AG Rob Bonta issued letters to eight large pharmacy chains and five health data companies reminding the companies of their obligations to comply with California’s Confidentiality of Medical Information Act (CMIA) and new requirements from Assembly Bill (AB 352), that went into effect on July 1, 2024. The letters remind the pharmacies that the CMIA prohibits…

Read More

AGs Secure $700 Million Judgment Against Johnson & Johnson over Talcum Probe

A bipartisan coalition of 43 AGs has entered into a Final Judgment and Consent Decree with Johnson & Johnson to resolve alleged violations of consumer protection laws related to its marketing of talc-based baby powder, which the AGs asserted contained asbestos about which the company failed to disclose associated cancer risks to consumers. Pursuant to the settlement,…

Read More

AGs Settle Opioid Epidemic-Related Claims Against Amneal Pharmaceuticals for $272.5M

A coalition of AGs reached a settlement in principle with Amneal Pharmaceuticals, Inc., to resolve allegations that it contributed to the opioid epidemic in its role as a drug manufacturer. According to the coalition, Amneal allegedly knowingly failed to monitor and report suspicious orders placed by its customers, as required by federal law. Under the…

Read More

CVS Settles with Alaska AG for $10 Million over Opioid Allegations

Alaska AG Treg Taylor has reached a settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated Alaska’s Unfair Trade Practices and Consumer Protection Act by allegedly dispensing opioid-containing prescription drugs without first making sufficient inquiries into the legitimacy of a prescription.

Read More